We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.75 | -3.53% | 20.50 | 20.00 | 21.00 | 21.25 | 20.50 | 21.25 | 875,556 | 14:55:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.46 | 53.42M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/10/2022 10:39 | The potential partners for signing contracts could not have seriously planned them until we got FDA clearance. Then they need to both establish new projects that can apply the technology and also negotiate the deal. Therefore, thinking about it the delay is to be expected. However in November I would expect the first of many more contract RNSs. Each one will boost the share price by 25p as revenues become clear and the snowball starts rolling. AN did very well to cash up till mid 2024 with the £4.5m r@d tax credit really helping. | purchaseatthetop | |
09/10/2022 10:34 | Most here (including myself) are naturally very disappointed with the share price post FDA. Had we now been at £1.20-£1.30, I.e. a drop after the usual ‘over spike’ on good news I imagine we would all have been quite happy to accept it is taking time to commercialise the technology. However, what is certain is the incredible medical and human value of Parsortix from removing the need for invasive usually non repetitive biopsy to regular downstream tests to both identify metastasis and help target effective treatment. Surely in a couple of years it will have become the ‘norm’ - but yes the virtue of patience can sometimes be very frustrating and wear thin after so many years ! | millwallfan | |
08/10/2022 14:18 | Ok, so let’s put it this way, is there any evidence to suggest that AN is the right person to run the business side? If so feel free to share. As I’ve mentioned previously there’s no doubt that what he has achieved is very good but he should have handed the reigns to someone with a good business brain POST FDA to move this on. There’s still time but it needs to be now before it’s too late. And perhaps the serial rampers every time it ticks up 2p can give it a rest. | antonagis | |
08/10/2022 13:04 | Message to sicilian kan: May I unequivocally add my name to those who deprecate the rubbish posters on this thread. Most of us will have long since filtered them - but others clearly haven't, and respond, which gives them the oxygen they crave. I plead to you as manager of this board: is there not a way of banning them permanently? They have nothing constructive to offer, and in at least one case have a personal animus against one poster which has absolutely no place here. Worse, the responses of others, however well-meant, themselves clutter the board and lower its quality. | pldazzle | |
08/10/2022 12:46 | It's like a spiral effect on selling pressure on illiquid stock. They are basically trying to put them to the wall ....Some of these characters on Advfn and LSE have got a FCA case open on them .... hopefully this time the evidence will stick !!! If your referring to me, regards face to face ... let's put it this way, some of these key board warriors on Advfn are going to get a rude awakening sooner p | amaretto1 | |
08/10/2022 12:41 | Your missing the point ...These creatures with there constant barrage all over many financial boards are actually putting companies in trouble... Most of there comments are unfounded and are specifically aimed at lowering the share price for there financial gain ... Small illiquid bio companies etc are backed in to a corner. Unable to raise money on acceptable terms for current shareholders! | amaretto1 | |
08/10/2022 12:20 | Joking apart , if this bulletin board was on social media and your identity was in the open and your contact details ie mobile number was available would some of you on here actually post this vitriolic nasty utterly awful claptrap that is more often than not posted . Alternatively would you actually face to face say the same ! I very much doubt it . A few on here epitomise a culture and society that is shallow with nothing to offer . A few posters on here want to really reconsider some of there actions and views and I dearly hope that they either don’t have children or if they do this part of there life is hidden from them as the apple never falls far from the tree and learnt behaviour is a very strong factor in a child’s future . Will neither reply or react to any negative replies to my diatribe | gibso6767 | |
08/10/2022 11:40 | Just a long list of filtered messages on my feed today.... | bagpuss67 | |
08/10/2022 11:23 | AMARETTO also very likely an employee using foul language after being rattled and exposed. This will very likely hit over well £1 later this decade if they’ve not run out of funds before any big deals take place. Unlikely with AN running the business side. | antonagis | |
08/10/2022 10:30 | Truant. 22/6/22 RNS. Signed contract. Everybody else waiting for FDA clearance and lab certification. First got, second soon. Now I am sure finalising deals as these take a long time to complete. | purchaseatthetop | |
08/10/2022 10:18 | As for PURCHASEATTHETOP his alleged buying has nothing to do with the clone. He’s allegedly bought and bought over and over since November 2020 albeit only 10000 or so the last few days… ALLEGEDLY. Paid ramper or employee of AGL? Make your own minds up. | antonagis | |
08/10/2022 10:16 | Definite sell and sit by the sidelines and watch. As I said, AN is clueless on the business side so watch this drift into obscurity like over 90% of AIM stocks have historically. | antonagis | |
08/10/2022 09:42 | to be clear i am not short AGL and don't intend to short | truant2tb1 | |
08/10/2022 09:41 | I was - mistakenly it seems - of the opinion AGL had useful IP with its Parsortix mechanism. Can anyone justify why there have been no deals signed so far? What's the rationale? Without thats it another AIM story stock and therefore a raging SELL / SHORT | truant2tb1 | |
08/10/2022 06:43 | Ahhh….Thailand | purchaseatthetop | |
07/10/2022 22:03 | I see that just a week after some very good news the usual suspects are baying for more news. Just how quickly do you think big pharma moves and have none of you ever experienced a bear market before? | arthur_lame_stocks | |
07/10/2022 21:39 | Very low volume day makes it incredibly easy to drop the price. Literally could be one individual or entity selling a small number of shares. I could’ve dropped the price today easily with the amount of stock I have. A total absence of buyers. I’d be surprised if the Jefferies note did not eventually lead to some II or HNWI buying on the back of it. Personally I will continue to add at these very low prices as and when funds permit! | dibs61 | |
07/10/2022 21:38 | antonagis, are you factoring into your calculations both purchaseatthetop's purchases and purchaseathetop's purchases or just purchaseatthetop's purchases? The extra "t" makes all the difference. | thailand | |
07/10/2022 18:59 | Sorry, yes. That's 2 years shy of 28 days. But why all the profanities? | antonagis | |
07/10/2022 18:48 | Filtered. Idiot. I started here Nov 2020. Whatever. | purchaseatthetop | |
07/10/2022 18:44 | Going back historically over the last 2 years PURCHASEATTHETOP must be on at least 1 million. That's actually a minimum. | antonagis |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions